Leukemoid reaction resulting from granulocyte colony-stimulating factor producing urothelial carcinoma of the renal pelvis

Kaohsiung Journal of Medical Sciences

Volumn 23, Issue 2, 2007, Pages 89-92

  Lin, Han Ching ^a   Chai, Chee Yin ^a,b   Su, Yue Chiu ^a   Wu, Wen Jeng ^a   Huang, Chun Hsiung ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Granulocyte colony stimulating factor; Leukemoid reaction; Renal pelvis; Urothelial carcinoma

Indexed keywords

CISPLATIN; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; HYPOXIA INDUCIBLE FACTOR 1; METHOTREXATE; VASCULOTROPIN; VINBLASTINE;

AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY PELVIS CARCINOMA; LEUKEMOID REACTION; LUNG METASTASIS; LYMPHADENECTOMY; MALE; NEPHRECTOMY;

EID: 33947166289     PISSN: 1607551X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1607-551X(09)70381-X     Document Type: Article

References (12)

1. Asano S, Urabe A, Okabe T, et al. Demonstration of granulopoietic factor(s) in the plasma of nude mice transplanted with a human lung cancer and in the tumor tissue. Blood 1997;49:845-52.
2. Fahey RJ. Unusual leukocyte responses in primary carcinoma of the lung. Cancer 1951;4:930-4.
3. Bradley TR, Metcalf D. The growth of mouse bone marrow cells in vivo. Aust J Exp Med 1986;44:287-99.
4. Hughes WF, Highley CS. Marked leukocytosis resulting from carcinogenesis. Ann Intern Med 1952;37: 1085-8.
5. Mizutani Y, Okada Y, Terachi T, et al. Serum granulocyte colony-stimulating factor levels in patients with urinary bladder tumor and various urological malignancies. Br J Urol 1995;76:580-6.
6. Tachibana M, Miyakawa A, Tazaki H, et al. Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte-colony stimulating factor. Cancer Res 1995;55:3438-43.
7. Higaki I, Hirohashi K, Fukushima S, et al. Renal pelvic carcinoma producing granulocyte colony-stimulating factor: report of a case. Surg Today 2001;31:266-8.
8. Terao S, Yamada Y, Shirakawa T, et al. Granulocyte-colony stimulating factor producing urothelial carcinoma of renal pelvis. Int J Urol 2005;12:500-2.
9. Inoue K, Slaton JW, Karashima T, et al. The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy. Clin Cancer Res 2000;6:4866-73.
10. Page EL, Robitaille GA, Pouyssegur J, et al. Induction of hypoxia-inducible factor-1 alpha by transcriptional and translational mechanisms. J Biol Chem 2002;277: 48403-9.
11. Biroccio A, Candiloro A, Mottolese M, et al. Bcl-2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression and in vivo angiogenesis in a breast carcinoma line. FASEB J 2000; 14:652-60.
12. Katoh O, Takahashi T, Oguri T, et al. Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor. Cancer Res 1998;58:5565-9.